top of page
News
Jul 25, 2022
Opinion: Congress should seize opportunity to cut medication costs for consumers
Prices are on the rise on just about every category of goods and services: food, housing, and healthcare. Consumers could use a break....
Jul 22, 2022
Opinion: These 'Rebates' Don't Result in Savings
Two former Trump administration officials have taken to the Wall Street Journal to defend the practices of pharmacy benefit managers, the...
Jul 21, 2022
Opinion: Drug Prices Are Falling, If You Know Where to Look
Prescription-drug prices are actually falling if you strip out the massive and growing rebates that pharmaceutical companies must pay to...
Jul 20, 2022
Powerful Senate Democrat outlines ‘plenty’ more drug pricing reforms to follow Medicare negotiation
Democrats may be closer than ever to passing sweeping drug pricing reforms, but Sen. Ron Wyden says there’s more to do. During a STAT...
Jul 15, 2022
Statement on Near-Term Congressional Efforts to Improve Prescription Drug Affordability
Congress should prioritize affordability of medicines needed by Medicare beneficiaries suffering from diabetes and other chronic...
Jul 3, 2022
Opinion: San Diegans with Mental Health Issues Forego Treatment Due to High Cost
Rising health care costs continue to put treatment out of reach for vulnerable communities in San Diego and across California, including...
Jul 2, 2022
FTC Goes After PBMs, Warns Of Legal Action
Last month, the Federal Trade Commission (FTC) voted unanimously (5-0) to examine rising list prices of insulin, but also to probe...
Jun 30, 2022
PBMs are inflating the cost of generic drugs. They must be reined in
hese are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit...
Jun 28, 2022
Former CVS exec accuses it of ripping off seniors, taxpayers
The top leadership of CVS Health directed an illegal scheme to work across the corporation’s sprawling subsidiaries to drive up drug...
Jun 27, 2022
Talking Solutions: The Story Behind Prescription Drug Prices In Nevada
According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across...
Jun 22, 2022
Senators unroll bipartisan plan to curb insulin prices
Top senators unveiled a bipartisan bill Wednesday that aims to curb the high cost of insulin, a lifesaving drug that some Americans have...
Jun 22, 2022
PBM reform bill that boosts FTC powers inches closer to passage in Senate
Legislation aimed at curbing several pharmacy benefit manager practices such as spread pricing cleared a key obstacle to passage in the...
Jun 21, 2022
Washington ups pressure on PBMs with more aggressive FTC policy, congressional ask for GAO study
Pressure is increasing on pharmacy benefit managers as the middlemen come under rising scrutiny from Washington for their role in rising...
Jun 17, 2022
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
The Federal Trade Commission voted unanimously yesterday (5-0) to adopt a new policy specifically targeting rising insulin prices, but...
Jun 16, 2022
Let My Doctors Decide: A VICTORY FOR PATIENTS
The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...
Jun 16, 2022
FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes
In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on notice that the agency will “ramp up...
Jun 15, 2022
The National Consumers League applauds the FTC’s decision to investigate PBMs
NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power...
Jun 15, 2022
Centene to pay $13.7M to settle PBM allegations in New Mexico
Centene will pay $13.7 million to settle more pharmacy benefit management overpayment allegations in Medicaid, this time in New Mexico....
Jun 9, 2022
The Truth about Pharmacy Benefit Managers
Nobody wants fraud — particularly not in medical care. Accordingly, in 1972, Congress passed the Federal Anti-kickback Statute that...
Jun 7, 2022
U.S. probes how pharmacies set drug prices as costs rise
The U.S. Federal Trade Commission has opened a probe into how big pharmacy benefit managers like CVS Caremark affect pricing and...
Jun 7, 2022
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
Agency to Scrutinize the Impact of Vertically Integrated Pharmacy Benefit Managers on the Access and Affordability of Medicine The...
Jun 7, 2022
FTC to Investigate CVS Caremark and Other Pharmacy-Benefit Managers
The Federal Trade Commission is probing CVS Caremark, CVS 0.94%▲ Express Scripts Inc. and other large pharmacy-benefits managers over...
May 24, 2022
Pharmacy Benefit Managers (PBMs) Harm Pharmacies and Patients Alike
Pharmacists play an essential role in the healthcare delivery system. Each day, their top priority is helping patients access medications...
May 24, 2022
PBM Accountability Project Applauds FTC for Examining the Cost-Increasing Impact of PBMs
The Executive Director of the PBM Accountability Project, Doug H. Dority, submitted public comment to the Federal Trade Commission (FTC)...
bottom of page